One platform. Two access routes.
A common core - ablation, monitoring and intelligence - designed for percutaneous and bronchoscopic ablation.
HEPTA's platform delivers microwave energy while its patented radiometry sensing technology acquires the data that powers real-time prediction — whichever route is used to reach the tumor.
Percutaneous ablation
Image-guided ablation delivered through the skin, with the introducer integrated into the device.
Different access. Same HEPTA intelligence — one sensing, prediction and visualization core beneath both routes.
A multidisciplinary team advancing real-time ablation monitoring.
HEPTA Medical was founded to close the gap between what physicians plan during tumor ablation and what they can see as treatment unfolds. The team brings together expertise in thermal therapies, medical devices, sensing and predictive software around one goal: real-time confidence in the operating room.
Gérard Hascoët
Chairman MD StartPhilippe Boucheron
Board Member BpifranceRobert Kwok
Board Member M&L HealthcarePauline de Breteuil
Board Member UI InvestissementJerome Edwards
Board Member IndependentPr Lambros Tselikas
Interventional Radiology Gustave RoussyPr Benjamin Bondue
Interventional Pulmonology Hôpital ErasmeDr Agathe Seguin
Thoracic Surgery Groupe Hospitalier Privé Ambroise Paré–HartmannDr Amir Hanna
Interventional Pulmonology Hôpital Marie-LannelongueSupported by investors and innovation partners.
In the press.
Cancer du poumon : Hepta Medical invente l'ablation thermique
Read article ↗Let's shape the next era of tumor ablation.
Connect with HEPTA to explore clinical, strategic and investment opportunities.
Contact us →HEPTA Medical — Chez DocCity
5–11 rue Gardenat Lapostol, 92150 Suresnes, France
contact@heptamed.com